Cardiokine
Philadelphia
About Cardiokine
Cardiokine, Inc., a specialty pharmaceutical company, engages in the development of pharmaceuticals for the prevention and treatment of cardiovascular diseases. Its products include lixivaptan, an orally active vasopressin receptor antagonist for patients with congestive heart failure who suffer from hyponatremia. The company was founded in 2004 and is headquartered in Philadelphia, Pennsylvania.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $87.0M
- Funding stage: M&A
- Last round: Series B (May 2006)
- Website: cardiokine.com
- Phone: 215-399-1200
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/cardiokine-2839147 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.